Cn Bio Innovations

The company provides the PhysioMimix suite of hardware, consumables, and assay protocols to recreate complex human biology for drug discovery. Their platforms enable the generation of human-specific efficacy, ADME, and safety data through single- and multi-organ models such as liver, lung, and gut-on-a-chip. These solutions are utilized by pharmaceutical companies and researchers to predict human drug responses and reduce reliance on animal testing.